Alterations of the cyclin-dependent kinase inhibitor genes CDKN2A, CDKN2B and CDKN2C in atypical and anaplastic meningiomas

被引：0
|
作者：
Boström, J
Meyer-Puttlitz, B
Blaschke, B
Wolter, M
Weber, RG
Lichter, P
Collins, VP
Reifenberger, G
机构：
[1] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany
[2] Univ Bonn, Med Ctr, Dept Neuropathol, D-5300 Bonn, Germany
[3] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany
[4] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
来源：
BRAIN PATHOLOGY | 2000年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [31] B1a cell expansion and autoimmunity promoted by cyclin-dependent kinase inhibitor Cdkn2c deficiency in a mouse model of lupus
    Potula, Hari Hara
    Xu, Zhiwei
    Zeumer, Leilani
    Morel, Laurence
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [32] Cyclin-Dependent Kinase Inhibitor Cdkn2c Deficiency Promotes B1a Cell Expansion and Autoimmunity in a Mouse Model of Lupus
    Potula, Hari-Hara S. K.
    Xu, Zhiwei
    Zeumer, Leilani
    Sang, Allison
    Croker, Byron P.
    Morel, Laurence
    JOURNAL OF IMMUNOLOGY, 2012, 189 (06): : 2931 - 2940
  • [33] Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids
    K. Duesing
    G. Fatemifar
    G. Charpentier
    M. Marre
    J. Tichet
    S. Hercberg
    B. Balkau
    P. Froguel
    F. Gibson
    Diabetologia, 2008, 51 : 821 - 826
  • [34] Cellular senescence molecules expression in type 2 diabetes mellitus: CDKN2A, CDKN2B, and lncRNA ANRIL
    Anaraki, Soheila
    Kheirandish, Masoumeh
    Mousavi, Pegah
    Tamandegani, Atefe Ebrahimi
    Mohammadi, Samane
    Shekari, Mohammad
    GENE, 2024, 911
  • [35] Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids
    Duesing, K.
    Fatemifar, G.
    Charpentier, G.
    Marre, M.
    Tichet, J.
    Hercberg, S.
    Balkau, B.
    Froguel, P.
    Gibson, F.
    DIABETOLOGIA, 2008, 51 (05) : 821 - 826
  • [36] PROGNOSTIC VALUE OF DELETIONS AND PROMOTER METHYLATION OF CDKN2A AND CDKN2B IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Braun, M.
    Pastorczak, A.
    Madzio, J.
    Taha, J.
    Ramiszewska, M.
    Matysiak, M.
    Derwich, K.
    Lejman, M.
    Kowalczyk, J.
    Badowska, W.
    Kazanowska, B.
    Szczepanski, T.
    Styczynski, J.
    Trelinska, J.
    Zalewska-Szewczyk, B.
    Irga-Jaworska, N.
    Mlynarski, W.
    HAEMATOLOGICA, 2015, 100 : 340 - 340
  • [37] Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A/P16) Polymorphisms and Risk of Pancreatic Neuroendocrine Tumors
    Campa, D.
    Rizzato, C.
    Capurso, G.
    Delle Fave, G.
    Gazouli, M.
    Landi, S.
    Buechler, M. W.
    Malecka-Panas, E.
    Boggi, U.
    Andriulli, A.
    Scarpa, A.
    Pasquali, C.
    Canzian, F.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 85 - 85
  • [38] Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
    Sock Hoai Chan
    Weng Khong Lim
    Scott T Michalski
    Jing Quan Lim
    Nur Diana Binte Ishak
    Marie Met-Domestici
    Cedric Ng Chuan Young
    Karen Vikstrom
    Edward D Esplin
    Jennifer Fulbright
    Mei Kim Ang
    Joseph Wee
    Kesavan Sittampalam
    Mohamad Farid
    Stephen E Lincoln
    Koji Itahana
    Syafiq Abdullah
    Bin Tean Teh
    Joanne Ngeow
    npj Genomic Medicine, 1
  • [39] CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours
    Rousseau, E
    Ruchoux, MM
    Scaravilli, F
    Chapon, F
    Vinchon, M
    De Smet, C
    Godfraind, C
    Vikkula, M
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (06) : 574 - 583
  • [40] Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
    José Luis Soto
    Carmen M Cabrera
    Salvio Serrano
    Miguel Ángel López-Nevot
    BMC Cancer, 5
12345